Skip to main content
SpringerLink
Log in

Prolactinoma

  • Chapter
  • First Online:
Pituitary Disease

Part of the book series: Endocrine Updates ((ENDO,volume 18))

Abstract

Prolactinomas are benign adenomas composed of lactotrophic cells of the pituitary gland that secrete excess amounts of the polypeptide hormone prolactin. They represent the most commonly diagnosed type of functioning pituitary tumour - that is, one that generates a clinical syndrome of hormone excess - and are a common cause of infertility in women. Lactotroph cells normally constitute about 20% of the cells in the normal human anterior pituitary gland, but their number and size increase during pregnancy. They are thought to derive from an embryonic mammosomatotroph cell precursor that produces both prolactin and growth hormone (1). In this chapter we will review briefly the key elements of prolactin physiology, and then consider the clinical presentation, diagnosis, treatment and monitoring of prolactinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asa, S.L., Kovacs, K., Horvath, E., Losinski, N.E., Laszlo, F.A., Domokos, I., and Halliday W.C. 1988. Human fetal adenohypophysis. Electron micro-scopic and ultrastructural immunocytochemical analysis. Neuroendocrinology. 48:423–31.

    Article  PubMed  CAS  Google Scholar 

  2. Truong, A.T., Duez, C., Belayew, A., Renard, A., Pictet, R., Bell, G.I., and Martial, J.A. 1984. Isolation and characterization of the human prolactin gene. EMBO J. 3:429–37.

    PubMed  CAS  Google Scholar 

  3. Evans, A.M., Petersen, J.W., Sekhon, G.S., and DeMars R. 1989. Mapping of prolactin and tumor necrosis factor-beta genes on human chromosome 6p using lymphoblastoid cell deletion mutants. Somat Cell Mol Genet. 15:203–213.

    Article  PubMed  CAS  Google Scholar 

  4. Peers, B., Voz, M.L., Monget, P., Mathy-Hartert, M., Berwaer, M., Belayew, A., and Martial, J.A. 1990. Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Mol Cell Biol. 10:4690–700.

    PubMed  CAS  Google Scholar 

  5. Berwaer, M., Monget, P., Peers, B., Mathy-Hartert, M., Bellefroid, E., Davis, J.R.E., Belayew, A., and Martial, J.A. 1991. Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol Cell Endocrinol. 80:53–64.

    Article  PubMed  CAS  Google Scholar 

  6. Poindexter, A.N., Buttram, V.C., Besch P.K., and Lash, B. 1977. Circulating prolactin levels. I. Normal females. Int J Fertil. 22:1–5.

    PubMed  CAS  Google Scholar 

  7. Davis, J.R.E, Selby, C., and Jeffcoate, W.J. 1984. Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol (Oxf). 20:427–34.

    Article  CAS  Google Scholar 

  8. Scheithauer, B.W., Sano, T., Kovacs, K.T., Young, Jr. W.F., Ryan, N., and Randall, R.V. 1990. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc. 65:461–474.

    Article  PubMed  CAS  Google Scholar 

  9. Ben-Jonathan, N., Mershon, J.L., Allen, D.L., and Steinmetz, R.W. 1996. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 17:639–69.

    PubMed  CAS  Google Scholar 

  10. Hoffman, W.H., Gala, R.R., Kovacs, K., and Subramanian, M.G. 1987. Ectopic prolactin secretion from a gonadoblastoma. Cancer. 60:2690–2695.

    Article  PubMed  CAS  Google Scholar 

  11. Ormandy, C.J., Camus, A., Barra, J., Damotte, D., Lucas, B., Buteau, H, Edery, M., Brousse, N., Babinet, C., Binart, N. et al. 1997. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11:167–78.

    Article  PubMed  CAS  Google Scholar 

  12. Bole-Feysot, C., Goffin, V., Edery, M., Binart, N. and Kelly, P.A. 1998. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 19:225–268.

    Article  PubMed  CAS  Google Scholar 

  13. Richards, S.M., and Murphy, W.J. 2000. Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function. J. Neuroimmunol. in press.

    Google Scholar 

  14. Reavley, A., Fisher, A.D., Owen, D., Creed, F.H, and Davis, J.R.E. 1997. Psychological distress in patients with hyperprolactinaemia. Clin Endocrinol (Oxf). 47:343–8.

    Article  CAS  Google Scholar 

  15. McNeilly, A.S. 1987. Prolactin and the control ofgonadotrophin secretion. J Endocrinol. 115:1–5.

    Article  PubMed  CAS  Google Scholar 

  16. Davis, J.R.E., Sheppard, M.C., and Heath, D.A. 1990. Giant invasive prolactinoma: a case report and review of nine further cases. Q J Med. 74:227–238.

    PubMed  CAS  Google Scholar 

  17. Walker, J.D., Grossman, A., Anderson, J.V., Ur, E., Trainer, P.J., Benn, J., Lowy, C., Sonksen, P.H., Plowman, P.N., Lowe, D.G., et al. 1993. Malignant prolactinoma with extracranial metastases: a report of three cases. Clin Endocrinol (Oxf). 38:411–419.

    Article  CAS  Google Scholar 

  18. Webster, J., Page, M.D., Bevan, J.S., Richards, S.H., Douglas-Jones, A.G., and Scanlon, M.F. 1992. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests. Clin Endocrinol (Oxf). 36:35–44.

    Article  CAS  Google Scholar 

  19. Bevan, J.S., Webster, J., Burke, C.W., and Scanlon, M.F. 1992. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev. 13:220–40.

    PubMed  CAS  Google Scholar 

  20. Leite, V., Cosby, H., Sobrinho, L.G., Fresnoza, M.A., Santos, M.A. and Friesen, H.G. 1992. Characterization of big, big prolactin in patients with hyperprolactinaemia. Clin Endocrinol (Oxf). 37:365–72.

    Article  CAS  Google Scholar 

  21. Hattori, N. 1996. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. J Clin Endocrinol Metab. 81:586–590.

    Article  PubMed  CAS  Google Scholar 

  22. Olukoga, A.O., and Kane, J.W. 1999. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf). 51:119–126.

    Article  CAS  Google Scholar 

  23. Heaney, A.P., Laing, I., Walton, L., Seif, M.W., Beardwell, C.G., and Davis, J.R.E. 1999. Misleading hyperprolactinaemia in pregnancy. Lancet. 353:720.

    Article  PubMed  CAS  Google Scholar 

  24. Stewart, P.M., Maheshwaran, S., Griffith, J., Li, J., Sheppard, M.C., Olliff, J., and Franklyn, J.A. 1993. Pituitary imaging is essential for women with moderate hyperprolactinaemia. Brit Med J 306:507–508.

    Article  PubMed  CAS  Google Scholar 

  25. Molitch, M.E., and Russell, E. J. 1990. The pituitary incidentaloma. Ann Intern Med. 112:925–931.

    PubMed  CAS  Google Scholar 

  26. Molitch, M.E. 1999. Diagnosis and treatment ofprolactinomas. Adv Intern Med. 44:117–153.

    PubMed  CAS  Google Scholar 

  27. Biller, B.M., Baum, H.B., Rosenthal, D.I., Saxe, V.C., Charpie, P.M., and Klibanski, A. 1992. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab. 75:692–697.

    Article  PubMed  CAS  Google Scholar 

  28. Cann, C.E., Martin, M.C., Genant, H.K., and Jaffe, R.B. 1984. Decreased spinal mineral content in amenorrheic women. JAMA. 251:626–629.

    Article  PubMed  CAS  Google Scholar 

  29. Klibanski, A., Neer, R.M., Beitins, I.Z., Ridgway, E.C., Zervas, N.T., and McArthur, J.W. 1980. Decreased bone density in hyperprolactinemic women. N Engl J Med. 303:1511–1514.

    Article  PubMed  CAS  Google Scholar 

  30. Klibanski, A., and Greenspan, S.L. 1986. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med. 315:542–546.

    Article  PubMed  CAS  Google Scholar 

  31. Klibanski, A., Biller, B.M., Rosenthal, D.I., Schoenfeld, D.A., and Saxe, V. 1988. Effects ofprolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab. 67:124–130.

    Article  PubMed  CAS  Google Scholar 

  32. Schlechte, J.A., Sherman, B., and Martin, R. 1983. Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab. 56:1120–1123.

    Article  PubMed  CAS  Google Scholar 

  33. Schlechte, J., el-Khoury, G., Kathol, M. and Walkner, L. 1987. Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab. 64:1021–1026.

    Article  PubMed  CAS  Google Scholar 

  34. Schlechte, J., Walkner, L., and Kathol, M. 1992. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. J Clin Endocrinol Metab. 75:698–703.

    Article  PubMed  CAS  Google Scholar 

  35. Koppelman, M.C., Kurtz, D.W., Morrish, K.A., Bou, E., Susser, J.K., Shapiro, J.R. and Loriaux, D.L. 1984. Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab. 59:1050–1053.

    Article  PubMed  CAS  Google Scholar 

  36. Greenspan, S.L., Neer, R.M., Ridgway, E.C., and Klibanski, A. 1986. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 104:777–782.

    PubMed  CAS  Google Scholar 

  37. Webster, J., Piscitelli, G., Olli, A., Ferrari, C.I., Ismail, I, and Scanlon, M.F. 1994. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med. 331:904–909.

    Article  PubMed  CAS  Google Scholar 

  38. Ferrari, C.I., Abs, R., Bevan, J.S., Brabant, G., Ciccarelli, E., Motta, T., Mucci, M., Muratori, M., Musatti, L., Verbessern, G., et.al.. 1997. Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin Endocrinol (Oxf). 46:409–413.

    Article  CAS  Google Scholar 

  39. Homburg, R., West, C., Brownell, J., and Jacobs, H.S. 1990. A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205–502, with bromocriptine in women with hyperprolactinaemia. Clin Endocrinol (Oxf). 32:565–571.

    Article  CAS  Google Scholar 

  40. Van der Heijden, P.F., de Wit, W., Brownell, J., Schoemaker, J., Rolland, R. 1991. CV 205–502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia. Eur J Obstet Gynecol Reprod Biol. 40:111–118.

    Article  PubMed  Google Scholar 

  41. Verhelst, J.A., Froud, A.L., Touzel, R., Wass, J.A., Besser, G.M., and Grossman, A.B. 1991. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. Acta Endocrinol (Copenh). 125:385–391.

    CAS  Google Scholar 

  42. Giusti, M., Porcella, E., Caftan, A., Cuttica, M., Valenti, S., and Giordano, G. 1994. A cross-over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinemic patients. J Endocrinol Invest. 17:51–57.

    PubMed  CAS  Google Scholar 

  43. Colao, A., De Rosa, M., Sarnacchiaro, F., Di Sarno, A., Landi, M.L., lervolino, E., Zarrilli, S., Merola, B., and Lombardi, G. 1996. Chronic treatment with CV 205–502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol. 135:548–552.

    Article  PubMed  CAS  Google Scholar 

  44. Serri, O., Rasio, E., Beauregard, H., Hardy, J., and Somma, M. 1983. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med. 309:280–283.

    Article  PubMed  CAS  Google Scholar 

  45. Tyrrell, J.B., Lamborn, K.R., Hannegan, L.T., Applebury, C.B., and Wilson, C.B. 1999. Transsphenoidal microsurgical therapy ofprolactinomas: initial outcomes and long-term results. Neurosurgery. 44:254–61; discussion 261–263.

    Google Scholar 

  46. Scanlon, M.F., Peters, J.R., Thomas, J.P., Richards, S.H., Morton, W.H., Howell, S., Williams, E.D., Hourihan, M., and Hall, R. 1985. Management of selected patients with hyperprolactinaemia by partial hypophysectomy. Brit Med J, 291:1547–1550.

    Article  CAS  Google Scholar 

  47. Scamoni, C., Balzarini, C., Crivelli, G., and Dorizzi, A. 1991. Treatment and long-term follow-up results of prolactin secreting pituitary adenomas. J Neurosurg Sci. 35:9–16.

    PubMed  CAS  Google Scholar 

  48. Bevan, J.S, Adams, C.B.T., Burke, C.W., et.al. 1986. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including preoperative bromocriptine therapy. Clinical Endocrinology. 26:541–556.

    Article  Google Scholar 

  49. Molitch, M. 1992. Pathologic hyperprolactinemia. Endocrinology and Metabolism Clinics of North America. 21:877–901.

    PubMed  CAS  Google Scholar 

  50. Fahlbusch, R., and Thapar, K. 1999. New developments in pituitary surgical techniques. In Bailliere’s Best Practice and Research, Clinical Endocrinology and Metabolism. Vol. 13 (3) `Pituitary Tumours’ J.R.E. Davis, Editor, Bailliere Tindall. 471–484.

    Google Scholar 

  51. Thoren, M., Rahn, T., Guo, W., and Werner, S. 1991. Stereotactic radio-surgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumours. Neurosurgery. 29:663–668.

    Article  PubMed  CAS  Google Scholar 

  52. Molitch, M.E. 1998. Pituitary diseases in pregnancy. Semin Perinatol. 22:457–70.

    Article  PubMed  CAS  Google Scholar 

  53. Touraine, P., Deneux, C., Plu-Bureau, G., Mauvais-Jarvis, P. and Kuttenn, F. 1998. Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia. J Endocrinol Invest. 21:732–736.

    PubMed  CAS  Google Scholar 

  54. Testa, G., Vegetti, W., Motta, T., Alagna, F., Bianchedi, D., Carlucci, C., Bianchi, M., Parazzini, F., and Crosignani, P.G. 1998. Two-year treatment with oral contraceptives in hyperprolactinemic patients. Contraception. 58:69–73.

    Article  PubMed  CAS  Google Scholar 

  55. Jeffcoate, W.J., Pound, N., Sturrock, N.D., and Lambourne, J. 1996. Longterm follow-up of patients with hyperprolactinaemia [see comments]. Clin Endocrinol (Ox fl. 45:299–303.

    Article  CAS  Google Scholar 

  56. Moriondo, P., Travaglini, P., Nissim, M., Conti, A., and Faglia, G. 1985. Bromocriptine treatment ofmicroprolactinomas: evidence of stable prolactin decrease after drug withdrawal. J Clin Endocrinol Metab. 60:764–772.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Manchester Royal Infirmary, Manchester, M13 9WL, UK

    A. J. Norris & J. R. E. Davis

Authors
  1. A. J. Norris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. E. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Birmingham, Birmingham, USA

    Michael C. Sheppard  & Paul M. Stewart  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Norris, A.J., Davis, J.R.E. (2002). Prolactinoma. In: Sheppard, M.C., Stewart, P.M. (eds) Pituitary Disease. Endocrine Updates, vol 18. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1115-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1115-1_5

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5401-7

  • Online ISBN: 978-1-4615-1115-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation